| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |